Dr. Shruti Gohil
Associate Medical Director, Epidemiology & Infection Prevention | UCI Health
Irvine, CA, UNITED STATES
Dr. Shruti K. Gohil is an infectious disease specialist in Orange, California and is affiliated with one hospital.
Media
Publications:
Documents:
Videos:
Audio/Podcasts:
Areas of Expertise (5)
Epidemiology of Sepsis
Infection Prevention
Clinical infectious diseases
Hospital Epidemiology
Sociodemographic
Education (1)
Tufts University School of Medicine: MD
Affiliations (2)
- Infectious Disease Society of America
- Society for Healthcare Epidemiologists of America
Links (5)
Media Appearances (10)
Orange County Grapples With Summer COVID Wave
Voice of OC online
2024-08-05
Orange County is grappling with another Summer COVID-19 wave as the positivity rate climbs to over 18% – a spike not seen in some time. Yet it’s not impacting hospitals anywhere near the levels of the initial waves in 2020 and 2021…That’s because of widespread vaccinations and previous infections, said Dr. Shruti Gohil, an infectious disease doctor at UC Irvine’s Medical Center in Orange. “We are seeing more COVID positivity among those tested, but hospitalizations overall due to COVID alone are low. And probably because that’s the success of the vaccine and overall immunity,” said Gohil, who treats COVID patients and a host of others. … But now, massive testing efforts – along with neighborhood test centers – have largely dried up, notes UCI epidemiologist Daniel Parker. He also noted that at-home tests don’t get reported to state and county officials, which makes it difficult to determine what the actual positivity rate is. “But all clues show us there is a wave right now,” Parker said, noting the uptick in COVID presence in wastewater surveillance.
Algorithm-driven alerts help identify best antibiotic for patients with pneumonia, UTI
Healio - Infectious Disease News online
2024-05-02
Two studies assessing the use of algorithm-driven prompts meant to improve antibiotic selection for patients hospitalized with pneumonia or UTIs showed the prompts were effective, researchers found. “Antibiotic resistance, which occurs when germs like bacteria and fungi mutate to defeat the drugs designed to kill them, is a major public health threat,” Shruti K. Gohil, MD, MPH, assistant professor of infectious diseases at the University of California Irvine School of Medicine and associate medical director of epidemiology and infection prevention in the Infectious Diseases School of Medicine, told Healio, adding that data show that 40% to 50% of patients hospitalized with pneumonia receive broad-spectrum antibiotics when they do not need them.
FDA Approves New Antibiotic Against UTIs
U.S. News & World Report online
2024-04-25
“This is an exciting new possibility for treatment of lower urinary tract infections,” Dr. Shruti Gohil, a professor of infectious diseases at the University of California, Irvine School of Medicine, told the Times. “But I would also say that it is going to be important that we use the drug responsibly in this country so that we don’t breed resistance against it.”
F.D.A. Approves Antibiotic for Increasingly Hard-to-Treat Urinary Tract Infections
The New York Times online
2024-04-24
“This is an exciting new possibility for treatment of lower urinary tract infections,” said Dr. Shruti Gohil, a professor of infectious diseases at the University of California, Irvine School of Medicine, and an author of a recent study in JAMA that focused on ways to reduce antibiotic overuse in hospitals. “But I would also say that it is going to be important that we use the drug responsibly in this country so that we don’t breed resistance against it.”
FDA Approves New Antibiotic Against UTIs
HealthDay News online
2024-04-25
“This is an exciting new possibility for treatment of lower urinary tract infections,” Dr. Shruti Gohil, a professor of infectious diseases at the University of California, Irvine School of Medicine, told the Times. “But I would also say that it is going to be important that we use the drug responsibly in this country so that we don’t breed resistance against it.”
New COVID Guidance, Variants and ‘Common Sense’: Living With the Coronavirus in 2024
KQED online
2024-01-18
The California Department of Public Health issued new COVID-19 guidance last week, advising that people may return to school and work even if they test positive for the virus. We’ll talk about California’s recommendations, the new COVID variant known as JN.1 and the latest developments in treatment and prevention. … Guests: … Dr. Shruti Gohil, associate medical director of epidemiology and infection prevention and professor of infectious diseases, University of California, Irvine School of Medicine.
CDC Issues Warning Over Deadly Tick-Borne Illness: What to Know
Healthline online
2023-12-12
The U.S. Centers for Disease Control (CDC) released a warning due to the rise of a condition called Rocky Mountain spotted fever. … Dr. Shruti Gohil (MD, MPH), an assistant professor of infectious diseases at the University of California, Irvine’s medical school, calls the disease “notorious” in her field and says there’s one particular age group that is at the most risk. “If you look at the really high-risk cases of people who actually go on to the die, it’s the younger ones, it’s children… Everybody’s at risk, sure, but children have a propensity for more severe consequences,” Gohil said.
Doctors Are Warning Of A ‘Tripledemic’ – What You Need To Know
LAist – AirTalk radio
2023-12-07
Flu is picking up steam while RSV lung infections that can hit kids and older people hard may be peaking, U.S. health officials said Friday. COVID-19, though, continues to cause the most hospitalizations and deaths among respiratory illnesses …. Joining us to discuss is Shruti Gohil, M.D., professor of medicine and associate medical director for epidemiology and infection prevention at UC Irvine’s School of Medicine.
Superbugs are on the rise. How can we prevent antibiotics from becoming obsolete?
Live Science print
2023-10-01
"When we give lots of antibiotics, or we give more broad antibiotics than are necessary, then you will breed more antibiotic resistance in a patient and in our populations," [said] Dr. Shruti Gohil, the associate medical director of the Epidemiology and Infection Prevention program [and an assistant professor] at the University of California, Irvine School of Medicine and a lead investigator of four INSPIRE-ASP Trials — federally funded research aimed at curbing the overuse of antibiotics in hospitals … The hope is that, by reigning in the misuse of antibiotics, we can reduce the rate that people get infected with multidrug-resistant organisms (MDROs), while also reducing the opportunities for new MDROs to emerge and spread between people.
COVID May Feel Like A Thing Of The Past, But Case Numbers Are Ticking Up This Summer. What’s Behind It?
LAist – AirTalk radio
2023-08-01
With us to talk about what’s contributing to this summer COVID spike is Dr. Shruti Gohil, [assistant] professor of medicine and associate medical director for epidemiology and infection prevention at UC Irvine’s School of Medicine.
Articles (5)
Impact of Policies on the Rise in Sepsis Incidence, 2000–2010
Clinical Infectious DiseasesShruti K. Gohil, Chenghua Cao, Michael Phelan, Thomas Tjoa, Chanu Rhee, Richard Platt, Susan S. Huang
2016 Sepsis hospitalizations have increased dramatically in the last decade. It is unclear whether this represents an actual rise in sepsis illness or improved capture by coding. We evaluated the impact of Centers of Medicare and Medicaid Services (CMS) guidance after newly introduced sepsis codes and medical severity diagnosis-related group (MS-DRG) systems on sepsis trends.
Marked reduction in compliance with central line insertion practices (CLIP) when accounting for missing CLIP data and incomplete line capture
American Journal of Infection ControlSK Scott, SK Gohil, K Quan, SS Huang
2016 Adherence to central line insertion practices can significantly reduce infections and is used as a hospital benchmark for quality. However, current national standards for central line insertion practices (CLIP) compliance calculation do not include missing CLIP forms. We found adherence rates significantly decreased when accounting for all lines at an academic medical center.
Healthcare Workers and Post-Elimination Era Measles: Lessons on Acquisition and Exposure Prevention
Clinical Infectious DiseasesShruti K. Gohil, Sandra Okubo, Stephen Klish, Linda Dickey, Susan S. Huang, Matthew Zahn
2016 When caring for measles patients, N95 respirator use by healthcare workers (HCWs) with documented immunity is not uniformly required or practiced. In the setting of increasingly common measles outbreaks and provider inexperience with measles, HCWs face increased risk for occupational exposures. Meanwhile, optimal infection prevention responses to healthcare-associated exposures are loosely defined. We describe measles acquisition among HCWs despite prior immunity and lessons from healthcare-associated exposure investigations during a countywide outbreak.
Impact of Hospital Population Case-Mix, Including Poverty, on Hospital All-Cause and Infection-Related 30-Day Readmission Rates
Clinical Infectious DiseasesShruti K. Gohil, Rupak Datta, Chenghua Cao, Michael J. Phelan, Vinh Nguyen, Armaan A. Rowther, Susan S. Huang
2015 Reducing hospital readmissions, including preventable healthcare-associated infections, is a national priority. The proportion of readmissions due to infections is not well-understood. Better understanding of hospital risk factors for readmissions and infection-related readmissions may help optimize interventions to prevent readmissions.
Regulatory Mandates for Sepsis Care — Reasons for Caution
The New England Journal of MedicineChanu Rhee, M.D., Shruti Gohil, M.D., M.P.H., and Michael Klompas, M.D., M.P.H.
2014 Sepsis, the syndrome of dysregulated inflammation that occurs with severe infection, affects millions of people worldwide each year. Multiple studies suggest that the incidence of sepsis is dramatically increasing. According to the Centers for Disease Control and Prevention (CDC), for example, sepsis rates doubled between 2000 and 2008.1 In 2010, sepsis was the 11th leading cause of death in the United States,2 and in 2011, it was the single most expensive condition treated in hospitals.
Social